These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 21793078)
21. Preliminary assessment of benign maxillofacial and neck lesions with in vivo single-voxel 1H magnetic resonance spectroscopy. Yu Q; Yang J; Wang P; Shi H; Luo J Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):264-70. PubMed ID: 17630099 [TBL] [Abstract][Full Text] [Related]
22. Conventional and advanced magnetic resonance imaging in tumefactive demyelination. Saini J; Chatterjee S; Thomas B; Kesavadas C Acta Radiol; 2011 Dec; 52(10):1159-68. PubMed ID: 22025739 [TBL] [Abstract][Full Text] [Related]
23. Accuracy of CT-guided biopsies in 359 patients with musculoskeletal lesions. Hau A; Kim I; Kattapuram S; Hornicek FJ; Rosenberg AE; Gebhardt MC; Mankin HJ Skeletal Radiol; 2002 Jun; 31(6):349-53. PubMed ID: 12073119 [TBL] [Abstract][Full Text] [Related]
24. Preliminary study of proton magnetic resonance spectroscopy in bone and soft tissue tumors: an unassigned signal at 2.0-2.1 ppm may be a possible indicator of malignant neuroectodermal tumor. Oya N; Aoki J; Shinozaki T; Watanabe H; Takagishi K; Endo K Radiat Med; 2000; 18(3):193-8. PubMed ID: 10972550 [TBL] [Abstract][Full Text] [Related]
25. Evaluation of ovarian tumors by proton magnetic resonance spectroscopy at three Tesla. Stanwell P; Russell P; Carter J; Pather S; Heintze S; Mountford C Invest Radiol; 2008 Oct; 43(10):745-51. PubMed ID: 18791417 [TBL] [Abstract][Full Text] [Related]
26. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI. Fayed N; Dávila J; Medrano J; Olmos S Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889 [TBL] [Abstract][Full Text] [Related]
27. Quantitative multivoxel proton chemical shift imaging of the breast. Sijens PE; Dorrius MD; Kappert P; Baron P; Pijnappel RM; Oudkerk M Magn Reson Imaging; 2010 Apr; 28(3):314-9. PubMed ID: 20071119 [TBL] [Abstract][Full Text] [Related]
29. [Evaluation of cerebral metabolism by multi-voxel proton magnetic resonance spectroscopy imaging in chronic unilateral internal carotid artery occlusion]. Takayama H; Suga S; Kobayashi M; Sadanaga F; Hozumi A; Kanai Y; Okamura M; Mihara B No To Shinkei; 2000 Apr; 52(4):307-12. PubMed ID: 10793417 [TBL] [Abstract][Full Text] [Related]
30. CT-guided needle biopsy for musculoskeletal lesions. Tsukushi S; Nishida Y; Yamada Y; Yoshida M; Ishiguro N Arch Orthop Trauma Surg; 2010 May; 130(5):699-703. PubMed ID: 20033699 [TBL] [Abstract][Full Text] [Related]
31. In vivo 1H MR spectroscopy of thyroid carcinoma. King AD; Yeung DK; Ahuja AT; Tse GM; Chan AB; Lam SS; van Hasselt AC Eur J Radiol; 2005 Apr; 54(1):112-7. PubMed ID: 15797300 [TBL] [Abstract][Full Text] [Related]
32. [Soft-tissue sarcomas of the extremities. Their assessment with magnetic resonance]. Masciocchi C; Barile A; Fascetti E; Gallucci M; Beomonte Zobel B; Passariello R Radiol Med; 1989; 77(1-2):80-6. PubMed ID: 2928568 [TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis of localized prostate cancer. Saito K; Kaminaga T; Muto S; Ide H; Nishio K; Kamiyama Y; Okada H; Terado Y; Furui S; Horie S Anticancer Res; 2008; 28(3B):1899-904. PubMed ID: 18630478 [TBL] [Abstract][Full Text] [Related]
34. Detection of liquid phase cholesteryl ester in carotid atherosclerosis by 1H-MR spectroscopy in humans. Duivenvoorden R; van Wijk D; Klimas M; Kastelein JJ; Stroes ES; Nederveen AJ JACC Cardiovasc Imaging; 2013 Dec; 6(12):1277-84. PubMed ID: 24269263 [TBL] [Abstract][Full Text] [Related]
35. Effect of contrast agent on the results of in vivo ¹H MRS of breast tumors - is it clinically significant? Baltzer PA; Gussew A; Dietzel M; Rzanny R; Gajda M; Camara O; Reichenbach JR; Kaiser WA NMR Biomed; 2012 Jan; 25(1):67-74. PubMed ID: 21557368 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic impact of proton MR-spectroscopy versus image-guided stereotactic biopsy. Setzer M; Herminghaus S; Marquardt G; Tews DS; Pilatus U; Seifert V; Zanella F; Lanfermann H Acta Neurochir (Wien); 2007; 149(4):379-86. PubMed ID: 17380247 [TBL] [Abstract][Full Text] [Related]
37. Bone and soft-tissue lesions: diagnosis with combined H-1 MR imaging and P-31 MR spectroscopy. Negendank WG; Crowley MG; Ryan JR; Keller NA; Evelhoch JL Radiology; 1989 Oct; 173(1):181-8. PubMed ID: 2675183 [TBL] [Abstract][Full Text] [Related]
38. Qualitative 3-T Proton MR Spectroscopy for the Characterization of Musculoskeletal Neoplasms: Update on Diagnostic Performance and Indications. Gondim Teixeira PA; Ledrich M; Kauffmann F; Wamba JM; Felblinger J; Blum A; Hossu G AJR Am J Roentgenol; 2017 Jun; 208(6):1312-1319. PubMed ID: 28301222 [TBL] [Abstract][Full Text] [Related]
39. [Oral-maxillofacial malignant tumors: an initial study with in vivo single-voxel 1H MR spectroscopy]. Yu Q; Wang PZ; Shi HM; Luo JC Zhonghua Kou Qiang Yi Xue Za Zhi; 2007 Jan; 42(1):18-20. PubMed ID: 17331436 [TBL] [Abstract][Full Text] [Related]
40. Combined DCE-MRI and single-voxel 2D MRS for differentiation between benign and malignant breast lesions. Lipnick S; Liu X; Sayre J; Bassett LW; Debruhl N; Thomas MA NMR Biomed; 2010 Oct; 23(8):922-30. PubMed ID: 20878970 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]